tiprankstipranks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market

Vir Biotechnology (VIR) Financial Statements

Compare
1,341 Followers

Vir Biotechnology Financial Overview

Vir Biotechnology's market cap is currently $888.69M. The company's EPS TTM is $-3.826; its P/E ratio is ―; Vir Biotechnology is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 74.20M$ 86.18M$ 1.58B$ 1.09B$ 67.25M
Gross Profit$ 73.36M$ 83.42M$ 1.43B$ 1.02B$ -234.33M
Operating Income$ -587.16M$ -684.30M$ 833.07M$ 276.89M$ -296.98M
EBITDA$ -537.61M$ -664.85M$ 833.07M$ 420.75M$ -289.80M
Net Income$ -521.96M$ -615.06M$ 515.84M$ 528.58M$ -298.67M
Balance Sheet
Cash & Short-Term Investments$ 990.38M$ 1.52B$ 2.40B$ 708.14M$ 736.86M
Total Assets$ 1.40B$ 1.92B$ 2.80B$ 1.95B$ 918.76M
Total Debt$ 90.14M$ 124.54M$ 127.97M$ 133.56M$ 66.56M
Net Debt$ -222.19M$ -117.04M$ -720.66M$ -214.25M$ -370.02M
Total Liabilities$ 248.43M$ 328.82M$ 724.13M$ 522.42M$ 201.91M
Stockholders' Equity$ 1.15B$ 1.59B$ 2.08B$ 1.43B$ 716.85M
Cash Flow
Free Cash Flow$ -453.65M$ -800.36M$ 1.60B$ -69.41M$ -197.49M
Operating Cash Flow$ -446.35M$ -778.78M$ 1.66B$ -47.59M$ -190.94M
Investing Cash Flow$ 499.37M$ 164.63M$ -1.19B$ -140.81M$ -9.86M
Financing Cash Flow$ 4.39M$ 7.48M$ 34.76M$ 100.33M$ 529.47M
Currency in USD

Vir Biotechnology Earnings and Revenue History

Vir Biotechnology Debt to Assets

Vir Biotechnology Cash Flow

Vir Biotechnology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis